Novartis AG is 25.8x more valuable than MADRIGAL PHARMACEUTICALS, INC. by market capitalization ($282.64 B vs $10.94 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MDGL | NVS |
|---|---|---|
| Market cap | $10.94 B | $282.64 B |
| US-listed rank | #897 | #47 |
| Revenue (latest FY) | $958.40M | - |
| Net income (latest FY) | -$288.28M | - |
| Net margin | -30.1% | - |
| SEC filings | 1,184 | 947 |
Novartis AG is 25.8x more valuable than MADRIGAL PHARMACEUTICALS, INC. by market capitalization ($282.64 B vs $10.94 B).
Full pages: MADRIGAL PHARMACEUTICALS, INC. and Novartis AG, or browse the full rankings.